BridgeMD
New treatment option for Hepatic
Official title Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill Hepatic Patients Admitted to Intensive Care Unit
ClinicalTrials.gov ID: NCT07642076
What this study is testing
What is L Carnitine?
L Carnitine is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for hepatic.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to evaluate the possible efficacy of l-carnitine in critically ill hepatic patients admitted to intensive care unit.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age more than 18 years old
- male or female with confirmed liver disease admitted to intensive care unit, including:
- Acute-on-chronic liver failure (ACLF)
- Hepatic encephalopathy
- spontaneous bacterial peritonitis (SBP)
You likely can't join if
- Age of less than 18 years old
- Pregnancy or Lactation
- patients have seizure
- patient on warfarin
See the full eligibility criteria
- Age more than 18 years old
- male or female with confirmed liver disease admitted to intensive care unit, including:
- Acute-on-chronic liver failure (ACLF)
- Hepatic encephalopathy
- spontaneous bacterial peritonitis (SBP)
- variceal bleeding
- fulminant hepatitis
- Hepatorenal syndrome
- Ascites
- Age of less than 18 years old
- Pregnancy or Lactation
- patients have seizure
- patient on warfarin
The study team makes the final eligibility decision.
Where it's taking place
- Menoufia, Egypt
Compensation & support
A stipend or compensation may be offered.
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Menoufia, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.